StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Trihexyphenidyl Hydrochloride

HCID 66007
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
52-49-3
Standard-SMILES
Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
InChIKey
QDWJJTJNXAKQKD-UHFFFAOYSA-N
Summenformel
C20H32ClNO
Durchschnittliche Molmasse
337,9 g/mol
Monoisotopische Masse
337,2172423

Überblick

Trihexyphenidyl hydrochloride is an aralkylamine.

Namen und Bezeichner

Bevorzugter Name
Trihexyphenidyl Hydrochloride
IUPAC
1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol;hydrochloride
Englischer Name
DL-Trihexyphenidyl hydrochloride
Summenformel
C20H32ClNO
Molmasse
337.93

Namen und Synonyme

Trihexyphenidyl hydrochloride52-49-3Trihexyphenidyl HClCyclodolParcopaneRomparkinCyclodolumTreminAparkaneTriphedinonSedrinaDTXSID8045802
Weitere Namen anzeigen
BENZHEXOL HCLDL-Trihexyphenidyl.HClTRIHEXYLPHENIDYL HYDROCHLORIDETrihxexyphenidyl HydrochlorideDL-Trihexyphenidyl hydrochlorideDL-Trihexyphenidyl hydrochlorideDL-TRIHEXYPHENIDYL HYDROCHLORIDE USP/EP/BPA-CYCLOHEXYL-A-PHENYL-1-PIPERIDINEPROPANOL, HCLDL-trihexyphenidyl hydrochloride, 10 mM in DMSO
NSC-757357AO61G82577Trihexyphenidyli hydrochloridumDTXCID60258021-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochlorideBroflexAgitaneBentex

Datenbank-Bezeichner

CAS
52-49-3、58947-95-8
PubChem CID
66007
DTXSID
DTXSID8045802
ChEMBL
CHEMBL1092
ChEBI
CHEBI:9721
UNII
AO61G82577
EC Number
200-142-5、627-735-5

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

Polarare Oberfläche (TPSA)
23,5 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
5
Schwere Atome
23
Formalladung
0
Komplexität
314

Experimentelle und physikochemische Eigenschaften

Solubility>50.7 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section174.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
258.5 °C · 258.5°C dec.
storage temp.
Refrigerator
Löslichkeit
2 O: · H2O: soluble
Aggregatzustand
solid
Farbe
white
Stabilität
Stable at RT
InChI
1S/C20H31NO.ClH/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21;/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2;1H
InChIKey
QDWJJTJNXAKQKD-UHFFFAOYSA-N
SMILES
Cl[H].OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

Danger

H301 (20%): Toxic if swallowed [Danger Acute toxicity, oral]

Gefahrenhinweise

Other Safety InformationIMAP assessments - 1-Piperidinepropanol, .alpha.-cyclohexyl-.alpha.-phenyl-, hydrochloride: Human health tier I assessment
Hazard Classes and Categories · 2 Einträge

Acute Tox. 3 (20%)

Acute Tox. 4 (100%)

Toxikologische Informationen

Treatment · 1 Eintrag

Treatment of acute overdose involves symptomatic and supportive therapy. Gastric lavage or other methods to limit absorption should be instituted. A small dose of diazepam or a short-acting barbiturate may be administered if CNS excitation is observed. Phenothiazines are contraindicated because the toxicity may be intensified due to their antimuscarinic action, causing coma. Respiratory support, artificial respiration or vasopressor agents may be necessary. Hyperpyrexia must be reversed, fluid volume replaced and acid-balance maintained. Urinary catheterization may be necessary. It is not known if Trihexyphenidyl is dialyzable. (L1712)

Exposure RoutesOral. Trihexyphenidyl is rapidly absorbed from the gastrointestinal tract.
Toxicity Summary · 1 Eintrag

Trihexyphenidyl is a selective M1 muscarinic acetylcholine receptor antagonist. It is able to discriminate between the M1 (cortical or neuronal) and the peripheral muscarinic subtypes (cardiac and glandular). Trihexyphenidyl partially blocks cholinergic activity in the CNS, which is responsible for the symptoms of Parkinson's disease. It is also thought to increase the availability of dopamine, a brain chemical that is critical in the initiation and smooth control of voluntary muscle movement.

Signs and SymptomsSymptoms of overdose include mydriasis, dryness of mucous membranes, red face, atonic states of bowels and bladder, and hyperthermia in high doses. Central consequences are agitation, confusion, and hallucinations.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Trihexyphenidyl hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
3
RTECS-Nr.
TN2625000
risk_code
22
hazard_code
Xn
safety_code
36
Speicherklasse
13 - Non Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesHalf Life: 3.3-4.1 hours
MeSH Pharmacological Classification · 2 Einträge

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

Verwendung und Herstellung

UsesIndicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs.
Anwendungen · 1 Eintrag

VerwendenDL-Trihexyphenidyl Hydrochloride is an anticholinergic tertiary amine that can gain access to the CNS. It is used to treat parkinsonism and the extrapyramidal side effects of anti-psychotic drugs. The drug is a muscarinic antagonist that qualitatively resembles the belladonna alkaloids in its pharmacological actions and side effects.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung